Fisher & Paykel Healthcare Corporation Limited ( (FSPKF) ) has issued an update.
Fisher & Paykel Healthcare Corporation Limited announced a transaction involving the transfer of shares from a trustee to Andrew Robert Donald Somervell, Vice President of Products & Technology, following the completion of a restrictive period for the 2022 Employee Share Purchase Plan. This transaction, which involved 35 ordinary shares valued at NZD $491.95, reflects the company’s ongoing commitment to employee engagement and retention through share ownership, potentially impacting its market positioning and stakeholder relations positively.
More about Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare Corporation Limited operates in the healthcare industry, specializing in the design, manufacture, and marketing of medical devices and systems for use in respiratory care, acute care, and the treatment of obstructive sleep apnea. The company focuses on innovative solutions to improve patient care and outcomes globally.
YTD Price Performance: -32.54%
Average Trading Volume: 369
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $11.56B
See more insights into FSPKF stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com